KBRA Releases Research – Update on KBRA Ratings in Path of Hurricane Ian
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases research on Hurricane Ian-related exposure to its rated Florida credits. Hurricane…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases research on Hurricane Ian-related exposure to its rated Florida credits. Hurricane…
BERKELEY, Calif.–(BUSINESS WIRE)–#careeradvancement–Undergraduate students from all across the globe descended on the UC Berkeley campus…
–(BUSINESS WIRE)–$KEYS #AI–Keysight Technologies, Inc. (NYSE: KEYS): What: As software development continues to evolve, testing…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases a report that examines CMBS 2.0 office lease expirations scheduled in…
SharkNinja Prevails on Key Patents, Winning Entirely on its Key Product Lines; SharkNinja is Prepared…
Collaboration between global payments technology provider and Middle East retail pioneer brings award-winning payment product…
SAINT LOUIS–(BUSINESS WIRE)–Perficient, Inc. (Nasdaq: PRFT) (“Perficient”), the leading global digital consultancy transforming the world’s…
Doorbuster savings are on now for PC components, TVs, audio and tech for home; customers…
KILGORE, Texas–(BUSINESS WIRE)–Martin Midstream Partners L.P. (“MMLP” or the “Partnership”) (NASDAQ: MMLP) announced the sale…
BIRMINGHAM, Ala.–(BUSINESS WIRE)–Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) today announced that…
DOVER, Del.–(BUSINESS WIRE)–Mana Capital Acquisition Corp. (“Mana Capital”) (Nasdaq: MAAQU; MAAQ; MAAQW; MAAQR), a publicly…
Integrated Offering Provides Group Healthcare Insurers Improved Risk Assessment through Access to Medical, Prescription and…
Speakers from Tinder Swindler and Biohacking to Microsoft and Google Working Together to Bridge the…
SAN DIEGO, Oct. 10, 2022 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…
MORRISVILLE, N.C., Oct. 10, 2022 (GLOBE NEWSWIRE) — Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty…
ROCKVILLE, Md., Oct. 10, 2022 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical…
Funds to be used to facilitate U.S. commercial launch of FUROSCIX® BURLINGTON, Mass., Oct. 10,…
SZN-043 preclinical data shows rapid, transient increases in hepatocyte proliferation and was well tolerated in…
REDWOOD CITY, Calif., Oct. 10, 2022 (GLOBE NEWSWIRE) — PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”),…
200 mg BID dose demonstrates receptor saturation and statistically significant increases in key circulating T…